In a March 2009 M&A Commentary titled “Lessons from the First Triggering of a Modern Poison Pill: Selectica, Inc. v. Versata Enterprises, Inc.,” Latham & Watkins LLP provided an insightful discussion of the important case pending in the Delaware Court of Chancery.  The case is particularly important for activist hedge funds whose investments in Delaware companies may, in certain circumstances, trigger poison pills.  We provide key parts of Latham’s discussion, and include video clips of testimony in the trial from the Delaware Court of Chancery, as provided by Courtroom View Network.